Hoodia
comes from a South African plant and is also called
Kalahari cactus
and Xhoba. The
San indigenous people (Bushmen)
live in an area that cuts across Angola, Botswana, Namibia, and South
Africa. They have long believed that this plant
acts as an appetite suppressant. They would use it to reduce their
hunger and thirst during long hunts.
It is marketed as a diet pill for weight loss to help curb cravings.
Hoodia
gordonii extract from the
plant's roots is made into powders, capsules, and chewable tablets.
They often contain other herbal supplements such as
green tea or
chromium picolinate.
Some research has shown
that a chemical classified as a steroidal glycoside has been isolated
from
Hoodia gordonii
and causes decreased appetite in animals. It is termed P57AS3, or just
P57. It likely acts on the central nervous system by increasing
ATP in the
hypothalamus.
In
obese diabetic rats given hoodia for up to eight weeks, diabetes was
reversed during those eight weeks.
Despite
all of this, there is no reliable scientific evidence on its use as
diet pills for weight loss, and there are only some preliminary
data on humans. On the same token, little is know about its side
effects. Therefore, it cannot be advised as a weight loss aid
at this time. This supplement supposedly does not have the stimulant
side effects of
other appetite suppressants.
Interestingly,
in
2003, the Council for Scientific and Industrial Research (CSIR) reached
an agreement with the San people to share any royalties on products
derived from the plant. This agreement is unique in that it
grants intellectual property rights for traditional knowledge rather
than a patent.
In 1997, the CSIR approached
Phytopharm, a company that develops drug from plants, to collaborate in
the development of the active ingredient.
Phytopharm
has a licensing agreement with
Pfizer to further market P57.